Here, the sustained activation of NRF2 due to KEAP1 LOF mutation was seen to promote tumor growth and upregulate the expression of PPP genes, including G6PD, TKT and PGD, through the epigenetic inhibition of miR-1 and miR-206, two repressors of metabolic gene induction. The gene discussed is KEAP1; the disease is neoplasm.